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ELISAA dessert matrix previously used for diagnosis of food allergies was incurred with pasteurised egg white or
skimmed milk powder at 3, 6, 15 and 30 mg allergen protein per kg of dessert matrix and evaluated as a
quality control material for allergen analysis in a multi-laboratory trial. Analysis was performed by immu-
noassay using ﬁve kits each for egg andmilk (based on casein) and six ‘other’ milk kits (ﬁve based on b-lac-
toglobulin and one totalmilk). All kits detected allergen protein at the 3 mg kg1 level. Based on ISO criteria
only one egg kit accurately determined egg protein at 3 mg kg1 (p = 0.62) and one milk (casein) kit accu-
rately determined milk at 6 (p = 0.54) and 15 mg kg1 (p = 0.83), against the target value. The milk ‘‘other’’
kits performed least well of all the kits assessed, giving the least precise analyses. The incurred dessert
material had the characteristics required for a quality control material for allergen analysis.
Crown Copyright  2013 Published by Elsevier Ltd. All rights reserved.ersity of
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The increased prevalence of food allergies and the fact that they
can be triggered by small quantities of foods, often ‘‘hidden’’ in
complex foods, has prompted the development of food allergen
labelling regulations across the world. Legislation has been imple-
mented to help allergic consumers to avoid problem foods and has
meant that, irrespective of their level of inclusion in a recipe, cer-
tain allergenic foods must always be listed on ingredient labels
(Mills et al., 2004). However, management of allergens that inad-
vertently ﬁnd their way into otherwise allergen free foods remains
problematic and manufacturers often resort to using precautionary
‘‘may contain’’ statements to warn consumers of potential aller-
genic hazards. Such allergen declarations often bear little relation-
ship to the likelihood of that product containing traces of the food
allergen in question (Heﬂe et al., 2007; Pele, Brohée, Anklam, &
van-Hengel, 2007) reducing their usefulness.
Effective food allergen management plans seek to minimise the
use of such labels, such as the Voluntary Incidental Trace Allergen
Labelling (VITAL) system in place in Australia, (Zurzolo, Mathai, Ko-
plin, & Allen, 2012). Such plans require access to well validated
methods of allergen analysis. Currently these are largely lacking,
partly because comparison of different allergen detection method-
ologies, such as enzyme-linked immunosorbent assay (ELISA),
polymerase-chain reaction (PCR) based methods, and mass spec-
trometry based methods, cannot be developed as incurred refer-
ence materials are not readily available (Heick, Fischer, &
Pöpping, 2011; Kerbach et al., 2009; Taylor, Nordlee, Niemann, &
Lambrecht, 2009). The complexity of food matrices and their lack
of stability over long periods of time (ideally several years) when
stored at ambient temperature makes the preparation of incurred
reference materials problematic. This is further complicated for
allergens where the hazard (and hence the analytical target of
choice) is a group of allergenic protein molecules, which are prone
to modiﬁcation, aggregation and interactions with other food com-
ponents (e.g., lipids and starches) in complex processed foodmatri-
ces (Mills, Sancho, Rigby, Jenkins, & Mackie, 2009). Although
certiﬁed reference materials, such as egg and skimmed milk pow-
der, are available and are being used as calibrants and standards in
commercial assays for allergen analysis, none have been designed
speciﬁcally for food allergen analysis. Calibrants and reference
materials may also contain levels of protein modiﬁcation atypical
for food ingredients such as skimmed milk powder, possibly as a
result of c-irradiation used to extend shelf-life (Johnson, Philo,
Watson, & Mills, 2012), and have not been evaluated with regards
their allergenic activity.
The ultimate veriﬁcation of a food ingredient’s allergenic activ-
ity is demonstrated by their ability to trigger an allergic reaction in
a food allergic individual. A range of food ingredients have been
used as the active components in oral food challenge procedures
used for diagnosis of food allergies in double blind placebo con-
trolled food challenge (DBPCFC) (Vlieg-Boerstra et al., 2011).
DBPCFC was a cornerstone of allergy diagnosis in the EuroPrevall
project (FOOD-CT-2005-514000) and made use of a standardised
food challenge dessert matrix in which dry powdered food ingredi-
ents, including peanut, hazelnut, celery spice, skimmed milk and
pasteurised egg white powder, could be blinded (Cochrane et al.,
2011; Mackie et al., 2012; Mills et al., 2007). Comprising cold
swelling starch, cocoa powder, sugar and a small amount of corn
oil and emulsiﬁer as a texturising agent, powdered allergenic
ingredients could be homogeneously incurred into the dessert ma-
trix base, which was then hydrated prior to consumption. The des-
sert base incurred with dry powdered ingredients has properties
similar to those required for analytical quality control material,
such as good microbiological stability at ambient temperature.The potential of the EuroPrevall dessert incurred with either
skimmed milk powder or pasteurised egg white powder as a qual-
ity control material for allergen analysis has been evaluated. These
powdered ingredients were selected because they are (1) used
widely by food manufacturers who have great difﬁculty in manag-
ing them in factories to avoid cross-contamination between pro-
cessing lines; and (2) were the type of ingredients used for
DBPCFC threshold studies in EuroPrevall; (3). Given the current
lack of certiﬁed reference materials for allergen analysis the perfor-
mance of the material has been assessed in a stringent manner
through a multi-laboratory trial using a range of commercially
available immunoassay test kits for determination of egg and milk
protein in foods. This has been undertaken in a manner consistent
with the principals and guidance provided by the AOAC Technical
Division on Reference Materials (http://www.aoac.org/imi-
s15_prod/Programs/RMG_ﬁles/RMG.htm).2. Materials and methods
2.1. Dessert manufacture
The dessert base was manufactured essentially as described by
Cochrane et al. (2011).
Egg white powder (declared protein content 78.56%) was pro-
vided by Colman’s of Norwich, UK. Skimmed milk powder (de-
clared protein content 36 ± 2%) was provided by Dairy Crest,
Nuneaton, UK. Powdered ingredients were used as raw or liquid
ingredients are less shelf-stable. Protein content was veriﬁed by
Kjeldahl analysis, the results of which were used to calculate the
level of egg white or milk powder incurred into the desserts. The
other ingredients used in the preparation of the dessert matrix
(icing sugar, cocoa powder and corn oil) were purchased from a lo-
cal supermarket. Dessert base was prepared containing either 0, 3,
6, 15 or 30 mg kg1 egg white protein or 0, 3, 6, 15 or 30 mg kg1
skimmed milk protein. Two 5 g aliquots of dessert incurred with
each allergen at each dose level together with the blank (zero aller-
gen) dessert, were reconstituted and analysed with regards aller-
gen content by ELISA (ELISA Systems Ltd. Enhanced egg residue
kit, Product code ESEGG-48 and Casein Residue test kit, Product
code ESCASPRD-48) according to the kit instructions. These analy-
ses conﬁrmed that the desserts were correctly assigned and con-
ﬁrmed the blank did not contain egg or milk powders above the
limit of detection (LoD) of the kit and that egg white and skimmed
milk powders were incurred in the correct relative proportions
(data not shown).
2.2. Immunoassay kits
The immunoassay kits for determination of egg and milk used
in this study are described in Table 1. Participating laboratories
were asked to follow the instructions provided by the kit manufac-
turers, including extraction procedures.
2.3. Study design
A total of 17 analytical laboratories participated in the ring trial
(22 including kit manufacturers). Participating laboratories were:
Campden BRI (UK), Paul-Ehrlich-Institut (Germany), CER Groupe
(Belgium), Premier Analytical Services (UK), Laboratory of the Gov-
ernment Chemist (LGC) (UK), Kent Scientiﬁc Services (UK), Glas-
gow Scientiﬁc Services (UK), Hampshire County Council (UK),
Euroﬁns (Germany), Unilever (UK), Reading Scientiﬁc Services
Ltd. (RSSL) (UK), Nestlé Research (Switzerland), FARRP, University
of Nebraska (USA), Health Canada (Canada), Public Analysts Labo-
Table 1
Test kit manufacturers, product codes and analytical targets of test kits used where available. BLG = b-lactoglobulin.
Kit manufacturer Kit description Analytical target
ELISA systems Enhanced egg ESEGG-48 Ovomucoid
Neogen 8450 – Veratox for egg Unknown
Morinaga Egg (ovalbumin) 10142 Ovalbumin
RBiopharm RIDASCREEN FAST Ei/egg R6402 Whole egg powder (NIST RM8445)
Romer AgraQuant egg white assay COKAL0848 Unknown
ELISA Systems Casein ESCASPRD-48 Casein
Neogen 8460 – Veratox casein Casein
Morinaga Casein 10152 Casein
RBiopharm RIDASCREEN FAST casein kit, R4612 Casein
Romer AgraQuant casein COKAL1200 Casein
ELISA systems BLG ESMRDBLG-48 BLG
Neogen 8470 – Veratox for total milk Unknown
Morinaga b-Lactoglobulin 10172 BLG
RBiopharm RIDASCREEN FAST b lactoglobulin kit, R4902 BLG
Romer AgraQuant b-lactoglobulin assay COKAL1048 BLG
Zeu ZE/PR/LS: proteon b-lactoglobulin BLG
32 P.E. Johnson et al. / Food Chemistry 148 (2014) 30–36ratory – Galway (Ireland), National Measurement Institute (NMI)
Australia (Australia), Food Allergens Control Training Analysis
(FACTa) Australia (Australia), R-Biopharm AG (Germany)⁄, ROMER
Labs UK (UK)⁄, Neogen Europe Ltd. (UK)⁄, Morinaga Institute of Bio-
logical Science (Japan)⁄, Elisa Systems (Australia)⁄ and ZEU-INMU-
NOTEC (Spain)⁄ (⁄denotes kit supplier).
Participating laboratories were provided with blinded dessert
material at each incurred allergen level, allergen test kits, and a
data return sheet (MS Excel) format (one per test kit). The data re-
turn sheets detailed trial-speciﬁc instructions (e.g., dilutions of
sample extracts to be used for analysis) in addition to the kit man-
ufacturer’s instructions. They also provided a mechanism whereby
participants could report deviations from trial protocol, or specify
conditions that were left to laboratory discretion in the assay kit
instructions. Calibrants were analysed in duplicate. Samples at
each level of incurred allergen were extracted in duplicate, and
each extract analysed in duplicate. A pre-ring trial was performed
involving 17 of the above laboratories to establish methodology
and increase familiarity with the dessert material and allergen test
kits used. Participating kit manufacturers only performed analysis
using their own kits.2.4. Data analysis
All laboratories returned full sets of data, three of which re-
ported nonconformities, two of which were due to user error
(incorrect extraction and dilution procedures) and one of which
was due to plate reader performance problems. These measure-
ments were excluded from the data analysis. Other data were only
excluded when a deviation from the assay protocols had been re-
corded. Raw data analysis was performed using Prism (version
5.01, GraphPad Software, Inc.) with the Boltzmann sigmoidal curve
ﬁtting algorithm to generate concentrations of protein in the kit
manufacturers units, correcting for sample dilutions. To allow
comparison of results from different test kits, data from each assay
were converted from the kit reporting units to either mg kg1 egg
white protein (w:w), or mg kg1 skimmed milk protein (w:w),
using a pre-assigned set of conversion factors (Table 2). These data
were then analysed using the ISO standard for method validation
(ISO5725-2, 1994) and The Ofﬁcial Methods for Analysis from
AOAC (Horwitz & Latimer, 2005) as the basis for statistical compar-
isons. Grubb’s test was used to test for outliers (i.e., labs whose
mean results were signiﬁcantly different (P < 0.05) to other labs).
Accuracy was assessed for each kit within each concentration using
a 1-sample t-test.3. Results
The levels of egg white powder and skimmed milk powder in-
curred into the dessert matrix were checked after preparation. This
analysis was performed using a single egg and milk (casein) test kit
and conﬁrmed the presence of egg white and skimmed milk pow-
ders in the correct relative proportions in each of the incurred des-
sert preparations. On average 43.9% and 51.2%, respectively of the
target level of egg white powder and for skimmed milk powder
was reported. The analyses also conﬁrmed the absence of egg in
the milk incurred dessert base and the absence of milk in the egg
incurred dessert base.
Following implementation of the ring trial, data returns from
each laboratory were used to ﬁt calibration curves obtained for
the egg (Fig. 1A–E), milk (casein; Fig. 1F–J) and milk (other;
Fig. 1K–P) kits. The latter group comprised ﬁve kits determining
the whey protein b-lactoglobulin (BLG) and one ‘‘total’’ milk kit.
In each case, the curves were ﬁtted to the means of all the data
as well as the means of data from the laboratories giving the lowest
and highest absorbance values for the calibration. All calibration
curves are shown individually in Figs. S1–S3. The best curve ﬁtting
(as judged by best r2 values) was obtained using a Boltzmann sig-
moidal curve for all kits apart from one each of the egg (kit 3), milk
(casein) (kit 4) and milk (other) (kit 5) kits for which a linear
regression was used. In some cases (egg kits 1, 2 and 5) the absor-
bance range obtained using the kit calibrants approached or ex-
ceeded three absorbance units, at which point plate-readers
often lose accuracy and no longer provide a linear response. Two
laboratories (14 and 19) returned data with several kits that was
signiﬁcantly different from the overall trial mean. In order to eval-
uate any potential matrix effect of the dessert, the absorbance val-
ues obtained in the detection of egg or milk analytes in the
0 mg kg1 (‘blank’) dessert samples, a buffer blank (non-template
controls, NTC) and the lowest calibrant were compared (Table 3).
Two egg kits (2 and 5) four of the milk ‘‘casein’’ kits and one of
the milk ‘‘other’’ kit (kit 3) showed a difference in the 0 mg kg1
and NTC values signiﬁcant at the 10% level. However, the magni-
tude of this difference is extremely small and the absorbance value
was lower than that of the lowest calibrant.
Allergen levels in the dessert were determined using the cali-
bration curves (Fig. 1) and reporting units converted into either
mg kg1 powdered egg white or skimmed milk powder protein
(c.f. factors in Table 2). Using this data, a full statistical analysis
was undertaken to evaluate the ‘‘trueness’’ of the reported analysis
at the different levels against the target value at which the allergen
had been incurred (Table 4). None of the kits used produced any
Table 2
Summary of accepted literature values for egg and milk protein contents used to derive conversion factors for this study. Kit reporting units were converted into common units
(egg white powder protein or skimmed milk powder protein) before between-kit comparisons were made.
Food Fraction Percentage (by weight) Reference(s)
HENS’ EGG Egg white in whole egg 69.6 Mine and Zhang (2002), Kovacs-Nolan et al. (2005)
Egg yolk in whole egg 30.4 Mine and Zhang (2002), Kovacs-Nolan et al. (2005)
Egg white protein 9.7–10.6 (mean 10.15) Mine and Zhang (2002), Kovacs-Nolan et al. (2005)
Egg white protein in egg white powder 84–91 (mean 85.5) Kovacs-Nolan et al. (2005)
Egg yolk protein 15.7–16.6 (mean 16.15) Mine and Zhang (2002), Kovacs-Nolan et al. (2005)
NIST RM 8445 whole egg powder–egg protein 47.5–48.5 (mean 48.0) NIST RM8445 documentation
Egg white protein in egg white powdera 81.6 FSA project Kjeldahl (experimental)
COWS’ MILK BLG in liquid skimmed milk 10.5 Bobe et al. (2007)
Milk protein in skimmed milk powdera 35.5 FSA project Kjeldahl (experimental)
Casein in skimmed milk protein 79.4 Ng-Kwai-Hang et al. (1987)
BLG = b-lactoglobulin.
a Indicates powdered ingredients used in the current study.
Fig. 1. Calibration curves for each of the 16 test kits used in the interlaboratory trial. Panels are as follows: (A–E) egg kits (1–5); (F–J) milk (casein) kits (1–5); (K–P) BLG/other
kits (1–6). The mean and standard deviation of data from all participating laboratories is shown together with the data from the laboratory returning the lowest and highest
absorbance values for each assay.
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levels incurred indicating that, in the range 3–30 mg kg1 protein,
the allergen concentration does not affect recovery. The variation
between reporting values for laboratories using egg test kits
(Fig. 2A–D) were smaller than for the milk (Fig. 2E–L) kits. All kits
underestimated the ‘‘target’’ concentration of egg in the samples;
kit 1 was the least accurate of the egg kits with kit 5 being the most
accurate at the 3 mg kg1 level according to the ISO criteria, reﬂect-
ing the fact this kit reported 97% of the incurred egg white protein
(Table 4).Like the egg kits, there was also a relatively wide spread of data
between laboratories for the individual milk (casein) kits (Fig. 2E–
H). Kit 1 was the most accurate of the ‘‘casein’’ kits and the only kit
that returned an estimated milk protein content with an accept-
able accuracy at the 6 and 15 mg kg1 levels. ‘‘Casein’’ kit 3 was
quite accurate but overestimated the casein concentrations com-
pared with target values. Again this is reﬂected in the fact that
‘‘casein’’ kit 1 reported 103% and 101% of the incurred protein at
the 6 and 15 mg kg1 levels, over-reporting at the 3 mg kg1 level
and under-reporting at the 30 mg kg1 level. However, results ob-
Table 3
Absorbance values obtained for egg kits for 0 mg kg1 dessert, non-template controls (NTC) and lowest non-zero calibrant.
Kit 0 mg kg1 Dessert (mean ± SD) Non-template control (mean ± SD) Lowest non-zero calibrant (mean ± SD) t-Test
Egg kits
Kit 1 0.088 ± 0.098 0.064 ± 0.083 0.466 ± 0.244 0.104
Kit 2 0.049 ± 0.093 0.029 ± 0.022 0.384 ± 0.085 0.041
Kit 3 0.055 ± 0.037 0.071 ± 0.087 0.100 ± 0.037 0.239
Kit 4 0.172 ± 0.275 0.145 ± 0.087 0.493 ± 0.744 0.367
Kit 5 0.098 ± 0.050 0.084 ± 0.043 0.278 ± 0.118 0.063
Milk ‘‘casein’’ kits
Kit 1 0.086 ± 0.063 0.068 ± 0.038 0.183 ± 0.148 0.037
Kit 2 0.061 ± 0.073 0.047 ± 0.029 0.514 ± 0.229 0.085
Kit 3 0.301 ± 0.417 0.195 ± 0.124 0.502 ± 0.210 0.023
Kit 4 0.065 ± 0.101 0.074 ± 0.211 0.381 ± 0.940 0.768
Kit 5 0.221 ± 0.106 0.192 ± 0.091 0.503 ± 0.133 0.097
Milk ‘‘other’’ kits
Kit 1 0.161 ± 0.216 0.124 ± 0.073 0.245 ± 0.100 0.170
Kit 2 0.307 ± 0.332 0.250 ± 0.180 0.410 ± 0.132 0.158
Kit 3 0.154 ± 0.078 0.066 ± 0.034 0.215 ± 0.108 2  1017
Kit 4 0.035 ± 0.072 0.027 ± 0.024 0.514 ± 0.192 0.301
Kit 5 0.070 ± 0.039 0.073 ± 0.052 0.268 ± 0.659 0.694
Kit 6 0.073 ± 0.071 0.073 ± 0.065 0.284 ± 0.157 0.954
‘t-Test’ is the result of a two-tailed non-paired t-test comparing both sets of 0 mg kg1 dessert data and NTC data.
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kits. Allergen levels reported from analyses undertaken with kits 2,
4 and 5 were less variable but also less accurate and led to under-
estimation of the concentration of milk in the samples, reporting
between 51–62% (kits 2 and 5) and 77–90% (kit 4) of the incurred
level of milk powder. Kit 3 consistently over reported the doses,
giving 120–134% of the incurred level of skimmed milk powder.
None of the milk (‘‘other’’) assays based either on b-lactoglobu-
lin (BLG) or on ‘‘total’’ milk detection (Fig. 2I and J) were able to re-
port the target value according to the ISO criteria although kit 6
was the most accurate. This reﬂects the fact that milk ‘‘other’’ kits
reported between 17% and 131% of the incurred protein. All the
other kits underestimated the milk concentration in the samples
relative to the target value with recoveries of <40%). ‘‘Other’’ milk
kit 6 returned the most anomalous data with three laboratories
producing inconsistent results. However, the level of variation for
this kit across the laboratories that produced anomalous data
was actually quite low, indicating the analytical basis of the kit is
reproducible but errors in implementation are common.
4. Conclusions
Over all the laboratories performed equally well, although two
(14 and 19) returned relatively high numbers of outlying data, nei-
ther of which participated in the pre-ring trial. A pre-ring trial
helps laboratories to become accustomed to working with a new
matrix and unfamiliar assay kits, and their value to establish meth-
odology is well accepted (Dumont et al., 2010; Abbott et al., 2010).
Variation in the quality of calibration curve data across multiple
laboratories using particular kits was observed, and demonstrates
the importance of including calibration for each immunoplate used
on the day of assay. Whilst the dessert matrix did have an effect on
the assay, as indicated by the non-template controls, these were all
below the limit of quantiﬁcation of the kits and consequently did
not give rise to any potential ‘‘false positive’’ results.
Estimations of allergen content in the dessert matrix varied be-
tween different kits, but were largely consistent within a kit at the
different levels at which pasteurised egg white or skimmed milk
powder had been incurred. All kits were able to detect the lowest
level (3 mg kg1) of either egg white protein or milk protein in-
curred into the dessert matrix. However, none of the ELISA test kits
were capable of returning the target level of incurred allergen in
the dessert matrix at all the allergen concentrations tested with,only one egg kit (kit 4) giving the true value of incurred allergen
and at one concentration (3 mg kg1 egg white protein). In general
all kits under-reported the levels of egg white and skimmed milk
powder incurred with the exception of milk (casein) kit 3, which
consistently over-estimated the milk content of the dessert at all
milk levels. The fact that this was not observed for the levels of
milk reported by the ‘‘casein’’ kits indicates this variability was
inherent to the assays themselves and unlikely to reﬂect problems
of homogeneity of incurred milk powder in the dessert.
In general, the allergen test kits were unable to report the target
values of the incurred pasteurised egg white or skimmed milk
powder. Overall, greater variability was found in the reported lev-
els of casein than those reported for egg, the milk (‘‘other’’) assays
being the least precise, with results from all the kits containing
many high and low outliers. ELISA kits designed to detect casein re-
ported more accurate results indicating they would be more appro-
priate to use when analysing foods likely to contain whole or
skimmed milks and caseinates. The data also indicate that there
are short-comings in the performance of many of the available
methods for detecting egg and milk in food, and raises issues of
how comparable test results may be between different kits given
the variability of results from different target analytes, antibodies,
procedural differences (incubations, washing, etc.), incomplete
protein extraction or lack of a common standard, or combinations
of these factors.
The variation in reported results may also be compounded by
the conversion from kit calibrants to standardised units for either
egg white or skimmed milk protein which can introduce system-
atic errors. Generation of factors to convert kit reporting units to
a standardised unit (in this study, egg white protein or skimmed
milk protein) is crucial to allow comparison of test kit results (La-
corn & Immer, 2010) and generate reporting units relevant in a
food manufacturing environment (e.g., the amount of egg or milk
in a sample). Factors also need to be carefully calculated to avoid
bias in the estimation of trueness of the level of incurred allergenic
ingredient. The common units presented here were deﬁned by the
consortium as a whole and could represent a starting point for such
discussion. However, it is clear that much remains to be done to
enable a wider consensus to be reached as to how assay output
data should be translated to standardised units.
Allergen analysis is often used by food manufacturers to vali-
date and monitor allergen sanitation plans. In this instance, a man-
ufacturer is likely to have access to the exact allergenic ingredient
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P.E. Johnson et al. / Food Chemistry 148 (2014) 30–36 35being analysed and, in some instances, the actual foodmatrix being
manufactured. This allows the analytical expert to calibrate an as-
say against this material or even have access to an ‘‘in-house’’ in-
curred reference material using the manufactured food matrix. In
such a situation, precise quantiﬁcation of the allergenic food and
conversion into food protein is possible (Röder et al., 2010)
although it may still be necessary to convert results obtained using
such ‘‘in-house’’ materials into reporting units that are more
widely accepted and accessible to the analytical community.
Precise quantiﬁcation of allergens in foods will be become more
important in the future as data are becoming available that will al-
low levels of allergens, which pose low levels of acceptable risk, to
be identiﬁed in future, such as the ‘action’ levels already identiﬁed
in VITAL. The enforcement of such regulations will require the per-
formance issues highlighted in this inter-laboratory study to be ad-
dressed in order to ensure effective tools for veriﬁcation of allergen
levels in foods are available. Such methods will need to be sufﬁ-
ciently robust as to allow detection of allergens of unknown origin,
which may be inherently variable with regards allergenic molecule
composition, modiﬁcations introduced by food processing proce-
dures (e.g., heat, pressure, pH) and interactions with other food
components such as lipids and sugars.
The dessert matrix used in this study would generally be con-
sumed in a 100 g portion and the kits used were all able to detect
doses of 300 lg egg or milk protein, which equates to 2.95 mg of
egg white and 8.5 ll of skimmed milk respectively. Such limits of
quantiﬁcation are within the range of published threshold doses
for egg of around 10 mg kg1 and for milk protein of around
30 mg kg1 (Morisset et al., 2003). However, lower doses of egg
and milk protein can elicit allergic reactions with around 1% of pa-
tients having been estimated as reacting to as little as 1 mg of egg
and milk (Moneret-Vautrin & Kanny, 2004), which the current
methodology would struggle to detect in certain types of foods
consumed in larger volumes.
The multi-laboratory evaluation reported here demonstrates
that the EuroPrevall dessert matrix does have promise as a natu-
rally incurred quality control material for food allergen analysis.
Further characterisation of the material, with regards homogeneity
and shelf-life will be required prior to making it more widely avail-
able as a quality control material. Nevertheless, the data presented
here represent an important step forward in making suchmaterials
available and hence support efforts to further improve the perfor-
mance of analytical tools for detection of allergens in food. A un-
ique aspect of the EuroPrevall dessert matrix is that it has been
used in DBPCFC to develop low-dose threshold data that will ulti-
mately contribute to the evidence base required for the develop-
ment of ‘‘action levels’’ for allergens in foods. The use of a matrix
and incurred food ingredients with demonstrable allergenic activ-
ity, for analytical purposes, will help ensure efforts to standardise
calibration materials and harmonisation of allergen reporting units
remain linked in a meaningful way to efforts to protect allergic
consumers from accidental exposure to problem foods.
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Fig. 2. Box-plots showing mean and variance of all returned data. Egg: A = 3 mg kg1 egg white protein, B = 6 mg kg1 egg white protein, C = 15 mg kg1 egg white protein,
D = 30 mg kg1 egg white protein; casein: E = 3 mg kg1 skimmed milk powder protein, F = 6 mg kg1 skimmed milk powder protein, G = 15 mg kg1 skimmed milk powder
protein, H = 30 mg kg1 skimmed milk powder protein; b-lactoglobulin: I = 3 mg kg1 skimmed milk powder protein, J = 6 mg kg1 skimmed milk powder protein,
K = 15 mg kg1 skimmed milk powder protein, L = 30 mg kg1 skimmed milk powder protein.
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